Abstract:Parkinson’s disease (PD) is one of the most common neurodegenerative diseases at present, and with the advent of aging society, there are significant increases in the incidence, prevalence, and mortality rates of this disease. A correct understanding of PD, continuous improvement of the accuracy of clinical diagnosis, and improvement in early diagnostic rate may help to actively cope with this challenge. With reference to the recent studies in related centers in China, this article reviews the current status of the diagnosis and treatment of PD and introduces the establishment of PD Biobank, the research on imaging and humoral markers, and the updates in treatment and related guidelines, in order to explain the current status of PD diagnosis and treatment and research advances in China over the past three years.
